15.12.20|CTech"GAG, through its healthcare arm, has extensive knowledge and experience in wound care and has a strong reach into the major clinical institutions in the UAE," said Sharon Malka, CEO of MediWound
07.01.20|Tzally GreenbergThe company’s product NexoBrid is a pineapple enzyme-based topical treatment for the removal of dead tissue from burn wounds
10.05.19|Micky GrunfeldThe agreement, for commercial rights in North America to Mediwound’s flagship burn treatment NexoBrid, could net the company up to $150 million
31.05.18|Dror ReichThe Nasdaq-listed, Israeli based company received the FDA’s approval to expand the use of flagship burn treatment NexoBrid to those suffering from Sulfur Mustard injuries
07.11.17|Amarelle Wenkert and Dror ReichThe story of Nasdaq-listed MediWound began with a German doctor, who searched for a way to treat the wounds of Wehrmacht soldiers stationed in North Africa